搜索结果: 1-15 共查到“肿瘤学 MANAGEMENT”相关记录41条 . 查询时间(0.235 秒)
Molecular insights influencing the management of head and neck cancers
Molecular insights head and neck cancers
2015/4/21
Head and neck cancers represent a clinically diverse group of tumours with distinctive molecular features. Understanding the importance of characteristic molecular changes has permitted the definition...
Neuroendocrine tumours–models for rare tumour management
Neuroendocrine tumours rare tumour management
2015/4/21
Neuroendocrine tumours have posed a challenge for the development of research and management strategies because of their rarity and heterogeneity, both from clinical and molecular perspectives. Classi...
Advances in our understanding and management of sarcomas–rare bone and soft tissue cancers
sarcomas rare bone and soft tissue cancers
2015/4/21
Bone and soft tissue sarcomas are rare, accounting for approximately 1% of all adult solid malignant tumors. Although these cancers are categorised under the same banner of ‘sarcoma’, they in fact rep...
Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer
PSA testing early management test-detected prostate cancer
2015/4/17
There is a consensus among relevant peak professional bodies, government and non-government organisations in Australia, that Australian clinical practice guidelines for prostate specific antigen (PSA)...
Keeping abreast of the evidence in management of colorectal cancer
management colorectal cancer
2015/4/13
The opportunity to host as Guest-Editor this issue
of Cancer Forum, has indeed been timely. The
unannounced rescindment by the National Health
and Medical Research Council’s Guideline of the
P...
Targeted therapies, aspects of pharmaceutical and oncological management
Targeted therapies oncological management
2015/4/8
A revolution is underway in cancer therapy and care. Now, based on identifying in a patient’s cancer those genetic
alterations that drive cancer growth, use of cancer therapy is more targeted and ca...
Merkel cell carcinoma is a rare, aggressive, cutaneous neuroendocrine tumour which has a propensity for both locoregional and distant spread. This review considers its epidemiology, diagnosis, staging...
NutritioNal maNagemeNt of patieNts with caNcer improves NutritioNal aNd quality of life outcomes
NutritioNal maNagemeNt life outcomes
2015/4/2
As new anti-cancer therapies continue to evolve it is important that supportive care, including effective nutrition
support, also improves to ensure best patient care and outcomes. Several sets of e...
Current issues in the nutritional management of patients with head and neck cancer in australia
nutritional management neck cancer
2015/4/2
The aim of this study was to provide a baseline measure of current dietetic practice throughout Australia in the care
of patients with head and neck cancer. An online survey was distributed to membe...
Sarcomas are a rare group of malignant mesenchymal tumours arising from bone and soft tissue. The diversity of this group of tumours and the rarity of each subtype poses significant challenges in the ...
Role of radiation therapy in the management of soft tissue sarcoma
radiation therapy soft tissue sarcoma
2015/4/1
External beam radiation therapy (pre-operative or post-operative) is an essential part of limb conservation in the management of soft tissue sarcoma of the extremity. The addition of radiation therapy...
Management of refractory dyspnoea: evidence-based interventions
refractory dyspnoea evidence-based interventions
2015/4/1
Breathlessness is a common and distressing symptom in both malignant and non-malignant conditions. Both pharmacological and non-pharmacological strategies are necessary to minimise symptom burden and ...
In palliative care, the presence of lymphoedema poses an interesting challenge for both patients and clinicians. When determining an appropriate management plan for a patient with advanced disease and...
The management of testicular cancer has changed dramatically over the last 30 years. Almost all patients with
early stage disease and over 80% of patients with advanced disease can now be cured with...
Hepatocellular carcinoma (HCC) is among the three most common causes of cancer death worldwide. Liver resection and liver transplantation are regarded as the standard curative treatment for hepatocell...